vs
Axil Brands, Inc.（AXIL）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
SUTRO BIOPHARMA, INC.的季度营收约是Axil Brands, Inc.的1.4倍（$11.6M vs $8.1M），Axil Brands, Inc.同比增速更快（5.2% vs -21.4%），过去两年Axil Brands, Inc.的营收复合增速更高（12.1% vs -5.4%）
Axil Brands是一家总部位于美国的专业消费电子企业，主营高端听力防护设备、音频增强装置及个性化音频配件，旗下产品涵盖定制耳塞、运动蓝牙耳机等，面向全球普通消费者及专业作业群体销售。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
AXIL vs STRO — 直观对比
营收规模更大
STRO
是对方的1.4倍
$8.1M
营收增速更快
AXIL
高出26.6%
-21.4%
两年增速更快
AXIL
近两年复合增速
-5.4%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.1M | $11.6M |
| 净利润 | $704.9K | — |
| 毛利率 | 68.1% | — |
| 营业利润率 | 11.1% | — |
| 净利率 | 8.7% | — |
| 营收同比 | 5.2% | -21.4% |
| 净利润同比 | 11.2% | 35.4% |
| 每股收益（稀释后） | $0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXILSTRO
| Q4 25 | $8.1M | $11.6M | ||
| Q3 25 | $6.9M | $9.7M | ||
| Q2 25 | $5.8M | $63.7M | ||
| Q1 25 | $6.9M | $17.4M | ||
| Q4 24 | $7.7M | $14.8M | ||
| Q3 24 | $5.9M | $8.5M | ||
| Q2 24 | $6.5M | $25.7M | ||
| Q1 24 | $6.5M | $13.0M |
净利润AXILSTRO
| Q4 25 | $704.9K | — | ||
| Q3 25 | $334.3K | $-56.9M | ||
| Q2 25 | $-245.6K | $-11.5M | ||
| Q1 25 | $576.7K | $-76.0M | ||
| Q4 24 | $633.7K | $-72.4M | ||
| Q3 24 | $-109.8K | $-48.8M | ||
| Q2 24 | $49.5K | $-48.0M | ||
| Q1 24 | $781.1K | $-58.2M |
毛利率AXILSTRO
| Q4 25 | 68.1% | — | ||
| Q3 25 | 67.6% | — | ||
| Q2 25 | 70.0% | — | ||
| Q1 25 | 71.7% | — | ||
| Q4 24 | 71.1% | — | ||
| Q3 24 | 71.0% | — | ||
| Q2 24 | 71.5% | — | ||
| Q1 24 | 71.5% | — |
营业利润率AXILSTRO
| Q4 25 | 11.1% | — | ||
| Q3 25 | 6.0% | -499.9% | ||
| Q2 25 | 0.8% | -5.2% | ||
| Q1 25 | 8.4% | -393.8% | ||
| Q4 24 | 8.7% | -440.7% | ||
| Q3 24 | -2.4% | -797.2% | ||
| Q2 24 | 2.6% | -189.4% | ||
| Q1 24 | -1.6% | -435.0% |
净利率AXILSTRO
| Q4 25 | 8.7% | — | ||
| Q3 25 | 4.9% | -586.6% | ||
| Q2 25 | -4.3% | -18.0% | ||
| Q1 25 | 8.3% | -436.6% | ||
| Q4 24 | 8.2% | -489.2% | ||
| Q3 24 | -1.9% | -572.6% | ||
| Q2 24 | 0.8% | -186.8% | ||
| Q1 24 | 12.1% | -447.5% |
每股收益（稀释后）AXILSTRO
| Q4 25 | $0.09 | — | ||
| Q3 25 | $0.04 | $-0.67 | ||
| Q2 25 | $-0.03 | $-0.14 | ||
| Q1 25 | $0.07 | $-0.91 | ||
| Q4 24 | $0.08 | $-27.63 | ||
| Q3 24 | $-0.02 | $-0.59 | ||
| Q2 24 | $0.11 | $-0.59 | ||
| Q1 24 | $0.04 | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.0M | $141.4M |
| 总债务越低越好 | $138.3K | — |
| 股东权益账面价值 | $11.1M | $-132.5M |
| 总资产 | $16.2M | $173.8M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资AXILSTRO
| Q4 25 | $5.0M | $141.4M | ||
| Q3 25 | $4.1M | $167.6M | ||
| Q2 25 | $4.8M | $205.1M | ||
| Q1 25 | $4.7M | $249.0M | ||
| Q4 24 | $5.2M | $316.9M | ||
| Q3 24 | $4.1M | $388.3M | ||
| Q2 24 | $3.3M | $375.6M | ||
| Q1 24 | $4.9M | $267.6M |
总债务AXILSTRO
| Q4 25 | $138.3K | — | ||
| Q3 25 | $139.2K | — | ||
| Q2 25 | $140.2K | — | ||
| Q1 25 | $141.0K | — | ||
| Q4 24 | $143.3K | — | ||
| Q3 24 | $144.3K | — | ||
| Q2 24 | $146.6K | — | ||
| Q1 24 | — | — |
股东权益AXILSTRO
| Q4 25 | $11.1M | $-132.5M | ||
| Q3 25 | $10.2M | $-87.3M | ||
| Q2 25 | $9.7M | $-32.1M | ||
| Q1 25 | $9.7M | $-25.8M | ||
| Q4 24 | $8.8M | $44.6M | ||
| Q3 24 | $7.9M | $111.2M | ||
| Q2 24 | $7.7M | $152.2M | ||
| Q1 24 | $8.8M | $98.0M |
总资产AXILSTRO
| Q4 25 | $16.2M | $173.8M | ||
| Q3 25 | $15.4M | $209.7M | ||
| Q2 25 | $12.9M | $262.4M | ||
| Q1 25 | $13.0M | $321.4M | ||
| Q4 24 | $13.7M | $387.2M | ||
| Q3 24 | $11.4M | $451.8M | ||
| Q2 24 | $11.0M | $489.0M | ||
| Q1 24 | $12.7M | $403.4M |
负债/权益比AXILSTRO
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.02× | — | ||
| Q3 24 | 0.02× | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $934.8K | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $906.4K | — |
| 自由现金流率自由现金流/营收 | 11.1% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | 1.33× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXILSTRO
| Q4 25 | $934.8K | $-177.2M | ||
| Q3 25 | $-739.2K | $-38.2M | ||
| Q2 25 | $194.4K | $-44.7M | ||
| Q1 25 | $-169.9K | $-67.9M | ||
| Q4 24 | $1.0M | $-71.7M | ||
| Q3 24 | $897.3K | $-64.5M | ||
| Q2 24 | $-336.6K | $9.5M | ||
| Q1 24 | $-912.8K | $-64.7M |
自由现金流AXILSTRO
| Q4 25 | $906.4K | — | ||
| Q3 25 | $-747.6K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-258.2K | — | ||
| Q4 24 | $941.1K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-394.9K | — | ||
| Q1 24 | $-922.1K | — |
自由现金流率AXILSTRO
| Q4 25 | 11.1% | — | ||
| Q3 25 | -10.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -3.7% | — | ||
| Q4 24 | 12.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.1% | — | ||
| Q1 24 | -14.3% | — |
资本支出强度AXILSTRO
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.3% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 0.1% | — |
现金转化率AXILSTRO
| Q4 25 | 1.33× | — | ||
| Q3 25 | -2.21× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.29× | — | ||
| Q4 24 | 1.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.80× | — | ||
| Q1 24 | -1.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
STRO
暂无分部数据
